EGM
DNTH icon

Engineers Gate Manager’s Dianthus Therapeutics DNTH Stock Holding History

Engineers Gate Manager’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.84M Sell
21,910
-1,470
-6% -$85.1K 0.02% 749
2025
Q4 		$963K Buy
23,380
+3,001
+15% +$116K 0.01% 1059
2025
Q3 		$802K Buy
+20,379
New +$521K 0.01% 1272
2024
Q2 		– Sell
-7,786
Closed -$234K – 1995
2024
Q1 		$234K Buy
+7,786
New +$169K 0.01% 1589
2023
Q1 		– Sell
-2,131
Closed -$13.5K – 1735
2022
Q4 		$13.5K Buy
+2,131
New +$37.7K ﹤0.01% 1624
2022
Q1 		– Sell
-948
Closed -$67K – 1951
2021
Q4 		$67K Buy
948
+317
+50% +$31.9K ﹤0.01% 1840
2021
Q3 		$74K Buy
+631
New +$73.5K ﹤0.01% 1559
2020
Q4 		– Sell
-756
Closed -$82K – 1758
2020
Q3 		$82K Buy
+756
New +$89.6K ﹤0.01% 1580

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Engineers Gate Manager's DNTH Position: Q1 2026 in Review

Engineers Gate Manager reduced its Dianthus Therapeutics (DNTH) stake by 6.3% in Q1 2026, selling an estimated $85.1K and leaving 21,910 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #749.

Engineers Gate Manager first reported a position in DNTH in Q3 2020 and has held it in 8 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Engineers Gate Manager held 21,910 shares of Dianthus Therapeutics worth $1.84M as of Q1 2026.
  • Engineers Gate Manager sold 1,470 Dianthus Therapeutics shares in Q1 2026, an estimated $85.1K.
  • Dianthus Therapeutics made up 0.02% of Engineers Gate Manager's portfolio in Q1 2026, its #749 holding.
  • Engineers Gate Manager first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 8 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.